PharmStars Announces 2021 Accelerator Graduates, Includes CBSA Member SmartTab
By: Colorado BioScience Association Date: 12/23/2021
12 digital health startups have successfully completed PharmStars’ inaugural 10-week pharma-focused accelerator program.
PharmStars, the pharma-focused accelerator for digital health startups, is delighted to announce the graduation of 12 startups from its fall 2021 inaugural program. The graduates successfully completed a 10-week accelerator program, which culminated at the Showcase Event on November 17-19 in Boston.
The Showcase Event brought together the participating startups and PharmStars’ innovation-minded pharma members. PharmStars’ six members include Boehringer Ingelheim, Eli Lilly and Company, Novo Nordisk, Sumitovant Biopharma, and others.
PharmStars focuses on bridging the “pharma-startup gap” by helping pharma and startups overcome partnership barriers. PharmStars’ unique PharmaU program provides education and mentorship that helps startups and pharma partner more effectively.
The first cohort was selected in September 2021 following a competitive application process. Each startup offers a novel digital health solution related to the theme “Innovations in Clinical Trials.” Their products represent a diverse array of digital health solutions, including digital biomarkers, patient engagement tools, clinical trial recruitment tools, novel drug delivery mechanisms, real-world evidence (RWE) collection capabilities, and data analysis tools.
At the Showcase Event, startups pitched pharma companies on their solutions and engaged with pharma representatives in one-on-one meetings. Participating startups said that the Showcase Event was extremely successful and positive. “Not just one, but all of our meetings over the past two days have been the most productive of any meetings in the five-year history of our company,” said the CEO of one of the startups.
The CEO of another participating startup said, “PharmStars is truly a game changer for the industry and is helping accelerate the digital transformation of pharmaceutical companies. We are proud to be part of the first-ever PharmStars cohort.”
Find out more in the press release.